Screening of Biomarkers and Related Mechanisms for RIX — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Screening of Biomarkers and Related Mechanisms for RIX — Stella

Home/Xerostomia Due to Radiotherapy (Disorder)/

View on ClinicalTrials.gov

Recruiting

Back to Xerostomia Due to Radiotherapy (Disorder) trials

Trial locations(3 sites)

China

Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu

Jiangsu Cancer Hospital, Nanjing, Jiangsu

The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu

Key details

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

Jinling Hospital, China, Jiangsu Cancer Institute & Hospital

Enrollment target

~200 participants

Started

May 2024

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.